Press "Enter" to skip to content

Statement from FDA Commissioner Scott Gottlieb, M.D., on new actions advancing the agency’s biosimilars policy framework

FDA announces new actions advancing the agency’s biosimilars policy framework

Original source: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm628121.htm

Also Read:   Statement on steps to make health care professional and patient labeling information for prescription medications consistent and clear